Author: VCTY

Microvast (NASDAQ: MVST) reported second-quarter revenue of $87.3 million, a 4.5% decline compared to the same period in 2025, driven by lower U.S. sales and […]

Odyssey Therapeutics (ODTX) reported a widening net loss for the second quarter of 2026, yet the company’s stock continues to gain momentum following a strategic […]

Interfor (TSX:IFP) has seen its fair value estimate jump to CA$15.17, up from the previous CA$12.75, as updated valuation models reflect a 19% shift in […]

Parker-Hannifin (NYSE: PH) smashed financial records in fiscal 2026, surpassing $20 billion in annual sales for the first time and posting an 18% increase in […]

Biogen reported its second-quarter 2026 financial results on Wednesday, July 29, 2026, highlighting a significant pivot toward sustainable revenue growth driven by its expanded portfolio […]

U.S. wine sales have plummeted to their lowest level in two decades, dropping below 300 million cases last year as shifting consumer preferences and a […]

Singapore’s economy expanded by 5.9% year-on-year in the second quarter of 2026, surpassing the government’s initial advance estimate of 5.7%, according to official data released […]

Equinix (EQIX) reported a standout second quarter on July 29, 2026, driven by an accelerating AI-led infrastructure cycle. The data center giant surpassed expectations, delivering […]

Parsons Corporation (PSN) delivered a robust second quarter in 2026, characterized by significant margin expansion and strong bookings, even as the company navigated strategic portfolio […]

To secure upcoming dividends from four specific companies, investors must purchase their shares no later than Tuesday, August 11, 2026. Because these stocks share a […]